Therefore, IFN-γ supports the promotion of tumorigenesis by immune evasion, in OSCC-GB patients, through activation of PDL1 transcription in tumor cells via the IL6/JAK/STAT3 signaling pathway. The gene discussed is IFNG; the disease is neoplasm.